Cargando…
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
Indoleamine 2, 3-dioxygenase 1 (IDO; IDO1; INDO) is a rate-limiting enzyme that metabolizes the essential amino acid, tryptophan, into downstream kynurenines. Canonically, the metabolic depletion of tryptophan and/or the accumulation of kynurenine is the mechanism that defines how immunosuppressive...
Autores principales: | Zhai, Lijie, Bell, April, Ladomersky, Erik, Lauing, Kristen L., Bollu, Lakshmi, Sosman, Jeffrey A., Zhang, Bin, Wu, Jennifer D., Miller, Stephen D., Meeks, Joshua J., Lukas, Rimas V., Wyatt, Eugene, Doglio, Lynn, Schiltz, Gary E., McCusker, Robert H., Wainwright, Derek A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308527/ https://www.ncbi.nlm.nih.gov/pubmed/32612606 http://dx.doi.org/10.3389/fimmu.2020.01185 |
Ejemplares similares
-
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
por: Zhai, Lijie, et al.
Publicado: (2021) -
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
por: Ladomersky, Erik, et al.
Publicado: (2019) -
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
por: Otto-Meyer, Sebastian, et al.
Publicado: (2019) -
Identification
and Characterization of a Novel Indoleamine
2,3-Dioxygenase 1 Protein Degrader for Glioblastoma
por: Bollu, Lakshmi R., et al.
Publicado: (2022) -
Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35-55)-induced experimental autoimmune encephalomyelitis
por: Wetzel, Lisa A., et al.
Publicado: (2020)